Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$1.33 - $3.1 $1,170 - $2,728
880 New
880 $2,000
Q4 2022

Feb 09, 2023

SELL
$1.96 - $2.61 $755,534 - $1.01 Million
-385,477 Reduced 91.56%
35,532 $70,000
Q3 2022

Nov 09, 2022

SELL
$2.02 - $3.62 $143,983 - $258,029
-71,279 Reduced 14.48%
421,009 $850,000
Q2 2022

Aug 11, 2022

BUY
$3.01 - $4.46 $1.12 Million - $1.66 Million
372,128 Added 309.69%
492,288 $1.57 Million
Q1 2022

May 12, 2022

BUY
$3.9 - $4.89 $24,593 - $30,836
6,306 Added 5.54%
120,160 $501,000
Q4 2021

Feb 11, 2022

BUY
$3.95 - $5.85 $308,502 - $456,896
78,102 Added 218.45%
113,854 $545,000
Q3 2021

Nov 12, 2021

BUY
$4.31 - $5.64 $50,483 - $66,061
11,713 Added 48.72%
35,752 $191,000
Q2 2021

Aug 10, 2021

SELL
$5.12 - $6.82 $5,606 - $7,467
-1,095 Reduced 4.36%
24,039 $123,000
Q1 2021

May 12, 2021

BUY
$4.74 - $7.38 $119,135 - $185,488
25,134 New
25,134 $169,000
Q4 2020

Feb 10, 2021

SELL
$3.95 - $5.42 $15,152 - $20,791
-3,836 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$3.54 - $5.27 $13,579 - $20,215
3,836 New
3,836 $15,000
Q2 2020

Aug 13, 2020

SELL
$2.87 - $5.46 $118,051 - $224,586
-41,133 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$2.46 - $5.35 $46,383 - $100,874
-18,855 Reduced 31.43%
41,133 $143,000
Q4 2019

Feb 10, 2020

BUY
$2.65 - $5.56 $56,278 - $118,077
21,237 Added 54.8%
59,988 $289,000
Q3 2019

Nov 12, 2019

BUY
$2.29 - $7.1 $85,417 - $264,830
37,300 Added 2570.64%
38,751 $112,000
Q2 2019

Aug 09, 2019

BUY
$6.44 - $14.29 $9,344 - $20,734
1,451 New
1,451 $10,000
Q4 2018

Feb 06, 2019

SELL
$13.09 - $21.49 $446,238 - $732,594
-34,090 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$16.4 - $24.27 $288,640 - $427,152
-17,600 Reduced 34.05%
34,090 $756,000
Q2 2018

Aug 14, 2018

BUY
$13.95 - $20.2 $721,075 - $1.04 Million
51,690 New
51,690 $848,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.25B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.